0 false false false false false false false false false false true false false false false false false No description of principal activity 2025-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 4,195,683 687,008 4,882,691 4,882,691 4,195,683 xbrli:pure xbrli:shares iso4217:GBP 14827807 2025-04-01 2026-03-31 14827807 2026-03-31 14827807 2025-03-31 14827807 2024-04-01 2025-03-31 14827807 2025-03-31 14827807 2024-03-31 14827807 bus:Director1 2025-04-01 2026-03-31 14827807 core:WithinOneYear 2026-03-31 14827807 core:WithinOneYear 2025-03-31 14827807 core:ShareCapital 2026-03-31 14827807 core:ShareCapital 2025-03-31 14827807 core:RetainedEarningsAccumulatedLosses 2026-03-31 14827807 core:RetainedEarningsAccumulatedLosses 2025-03-31 14827807 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 14827807 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 14827807 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 14827807 core:Non-currentFinancialInstruments 2026-03-31 14827807 core:Non-currentFinancialInstruments 2025-03-31 14827807 bus:SmallEntities 2025-04-01 2026-03-31 14827807 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 14827807 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 14827807 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 14827807 bus:FullAccounts 2025-04-01 2026-03-31 14827807 core:AllAssociates 2025-04-01 2026-03-31
COMPANY REGISTRATION NUMBER: 14827807

Marlowe Consulting Services Ltd

Filleted Unaudited Financial Statements

31 March 2026

Marlowe Consulting Services Ltd

Financial Statements

Year ended 31 March 2026

Contents | Page

Statement of financial position | 1

Notes to the financial statements | 2

Marlowe Consulting Services Ltd

Statement of Financial Position

31 March 2026

| 2026 | 2025
Note | £ | £ | £

Fixed assets

Investments | 4 |  | 4,882,691 | 4,195,683

Current assets

Cash at bank and in hand | 595 |  | 1,248

Creditors: amounts falling due within one year | 5 | 24,928 |  | 40,912
| -------- |  | --------
Net current liabilities |  | 24,333 | 39,664
|  | ------------ | ------------
Total assets less current liabilities |  | 4,858,358 | 4,156,019
|  | ------------ | ------------
Net assets |  | 4,858,358 | 4,156,019
|  | ------------ | ------------

Capital and reserves

Called up share capital |  | 100 | 100
Profit and loss account |  | 4,858,258 | 4,155,919
|  | ------------ | ------------
Shareholders funds |  | 4,858,358 | 4,156,019
|  | ------------ | ------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 18 June 2026 , and are signed on behalf of the board by:

Ms A L Andresen
Director

Company registration number: 14827807

Marlowe Consulting Services Ltd

Notes to the Financial Statements

Year ended 31 March 2026
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Camburgh House, 27 New Dover Road, Canterbury, Kent, CT1 3DN, England.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Consolidation
The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the company and its subsidiary undertakings comprise a small group.
Investments
Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.
Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.
Investments in associates
Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.
Investments in joint ventures
Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
4. Investments

| Shares in group undertakings
| £
Cost |
At 1 April 2025 | 4,195,683
Additions | 687,008
| ------------
At 31 March 2026 | 4,882,691
| ------------
Impairment |
At 1 April 2025 and 31 March 2026 | –
| ------------

Carrying amount |
At 31 March 2026 | 4,882,691
| ------------
At 31 March 2025 | 4,195,683
| ------------

5. Creditors: amounts falling due within one year

| 2026 | 2025
| £ | £
Other creditors | 24,928 | 40,912
| -------- | --------

6. Related party transactions
At the balance sheet date the company owed a director £24,500 (2025: £40,500).